English | Español
Gene Johnson | Mar 25, 2017

AstraZeneca receives complete response letter from FDA
Gene Johnson | Mar 24, 2017

Pfizer's antibiotic drug Zavicefta available in Germany, United Kingdom
Gene Johnson | Mar 24, 2017

AstraZeneca, Circassia Pharmaceuticals partner to develop respiratory drugs

Gene Johnson | Mar 24, 2017

China approves Xeljanz to treat moderate to severe rheumatoid arthritis
Gene Johnson | Mar 24, 2017

FDA approves new drug for the treatment of advanced breast cancer in women

John Breslin | Mar 23, 2017

Lawmakers promise timely renewal of drug fee agreements

Gene Johnson | Mar 21, 2017

FDA approves Merck's Keytruda for treating Hodgkin lymphoma
Gene Johnson | Mar 21, 2017

GlaxoSmithKline submits supplemental application to the FDA for its flu vaccine

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’